10x Genomics
TXG
76.10
-4.56
-5.65%
10x Genomics
US · TXG
#1311 by market cap
Listed 2019
76.10
-4.56
-5.65%
Live - 5344 symbols - heartbeat 110s ago
· 2026-10-08 06:44
Pre-market
73.50
-3.42%
After-hours
76.20
+0.13%
Overnight
75.78
-0.42%
- Market cap
- 9.92B
- P/E (TTM)i
- -128.98
- P/Bi
- 12.01
- EPSi
- -0.35
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on TXG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 7.2 percentage points.
Institutional ownership
- Held by institutions
- 104.18% +7.24pp
- Institutions
- 459
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund85.55%
Hedge Fund9.67%
Individual/Insider7.79%
Public Company4.19%
VC/PE Fund1.37%
Private Company1.33%
Government Pension Fund0.76%
Family Office/Trust0.69%
Insurance Company0.40%
Top holders
FMR
14.22%
T. Rowe Price Group, Inc.
11.75%
BlackRock
8.29%
ARK Investment Management LLC
7.68%
Vanguard Portfolio Management, LLC
5.36%
Vanguard Capital Management, LLC
4.54%
Quantinno Capital Management LP
4.21%
Amova Asset Management
3.22%
Serge Saxonov
3.16%
Benjamin Hindson
2.55%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 13 buys · 37 sells
| Name | Role | Stake |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | 3.16% |
| Benjamin Hindson | Co-Founder, President, Chief Scientific Officer & Director | 2.55% |
| John Stuelpnagel | Independent Chairperson | 1.86% |
| Adam Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | 0.08% |
| Alan Mateo | Director | 0.05% |
| Sridhar Kosaraju | Independent Director | 0.05% |
| Kimberly Popovits | Independent Director | 0.02% |
| Shehnaaz Suliman | Independent Director | 0.01% |
| Sarah Teichmann | -- | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-21 | Shehnaaz Suliman | Independent Director | Automatic Disposition | -5,723 | $78.20–82.28 |
| 2026-09-21 | Serge Saxonov | Chief Executive Officer | Automatic Disposition | -25,000 | $78.23–82.37 |
| 2026-09-08 | Adam Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | Automatic Disposition | -46,388 | $63.68–65.26 |
| 2026-09-02 | John Stuelpnagel | Independent Chairperson | Open Market Disposition | -20,000 | $60.66–62.61 |
| 2026-08-31 | Serge Saxonov | Chief Executive Officer | Other Disposition | -100 | -- |
| 2026-08-25 | Serge Saxonov | Chief Executive Officer | Automatic Disposition | -10,486 | $63.02–64.75 |
| 2026-08-23 | Shehnaaz Suliman | Independent Director | Automatic Disposition | -2,207 | $62.73–63.97 |
| 2026-08-23 | Adam Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | Open Market Disposition | -17,166 | $63.02 |
| 2026-08-23 | Serge Saxonov | Chief Executive Officer | Open Market Disposition | -18,545 | $63.02 |
| 2026-08-23 | Benjamin Hindson | Co-Founder, President, Chief Scientific Officer & Director | Open Market Disposition | -13,818 | $63.02 |
| 2026-08-19 | Serge Saxonov | Chief Executive Officer | Other Disposition | -4,000 | -- |
| 2026-08-13 | Sarah Teichmann | -- | Automatic Disposition | -7,551 | $57.15–57.29 |
| 2026-08-13 | Sarah Teichmann | -- | Intent to Sell (Form 144) | -2,273 | $57.15 |
| 2026-08-12 | Sarah Teichmann | -- | Intent to Sell (Form 144) | -5,278 | $57.29 |
| 2026-08-10 | John Stuelpnagel | Independent Chairperson | Open Market Disposition | -20,000 | $57.58–58.73 |
| 2026-06-21 | Serge Saxonov | Chief Executive Officer | Automatic Disposition | -30,000 | $33.29–36.16 |
| 2026-06-15 | Shehnaaz Suliman | Independent Director | Automatic Disposition | -5,723 | $32.59–33.27 |
| 2026-06-03 | Kimberly Popovits | Independent Director | Other Acquisition | +8,829 | -- |
| 2026-06-03 | John Stuelpnagel | Independent Chairperson | Other Acquisition | +8,829 | -- |
| 2026-06-03 | Shehnaaz Suliman | Independent Director | Other Acquisition | +8,829 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:44:45 · For reference only, not investment advice and not tailored to your situation.